Cinctive Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,516	Closed	-$245K	–	398
2024 Q4	$245K	Sell	9,516 -57,055	-86%	-$1.47M	0.01%	321
2024 Q3	$1.11M	Buy	66,571 +29,115	+78%	+$483K	0.06%	270
2024 Q2	$720K	Buy	37,456 +22,415	+149%	+$431K	0.03%	310
2024 Q1	$356K	Buy	+15,041	New	+$356K	0.02%	339